Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors
- Resource Type
- Journal
- Authors
- Sootome, Hiroshi; Fujita, Hidenori; Ito, Kenjiro; Ochiiwa, Hiroaki; Fujioka, Yayoi; Ito, Kimihiro; Miura, Akihiro; Sagara, Takeshi; Ito, Satoru; Ohsawa, Hirokazu; Otsuki, Sachie; Funabashi, Kaoru; Yashiro, Masakazu; Matsuo, Kenichi; Yonekura, Kazuhiko; Hirai, Hiroshi
- Source
- CANCER RESEARCH; NOV 2020, 80 22, p4986-p4997, 12p.
- Subject
- Language
- English
- ISSN
- 15387445